Encompass Health (NYSE:EHC) Issues FY24 Earnings Guidance

Encompass Health (NYSE:EHC) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $3.86-4.11 for the period, compared to the consensus earnings per share estimate of $3.98. The company issued revenue guidance of $5.250-5.325 billion, compared to the consensus revenue estimate of $5.25 billion.

Encompass Health Trading Down 0.0 %

NYSE:EHC traded down $0.04 during trading hours on Thursday, hitting $82.76. 524,673 shares of the stock were exchanged, compared to its average volume of 660,172. The company has a market capitalization of $8.29 billion, a P/E ratio of 23.57, a price-to-earnings-growth ratio of 1.53 and a beta of 0.94. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 1.19. The company’s 50 day moving average is $77.89 and its two-hundred day moving average is $70.67. Encompass Health has a twelve month low of $57.55 and a twelve month high of $85.84.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $0.93 by $0.19. The firm had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. The company’s revenue was up 13.4% on a year-over-year basis. During the same period last year, the company earned $0.88 earnings per share. On average, sell-side analysts anticipate that Encompass Health will post 3.96 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a $0.15 dividend. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 annualized dividend and a dividend yield of 0.72%. Encompass Health’s dividend payout ratio is currently 17.29%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on EHC. Royal Bank of Canada restated an outperform rating and set a $83.00 price objective on shares of Encompass Health in a report on Friday, February 9th. Truist Financial boosted their price target on shares of Encompass Health from $82.00 to $86.00 and gave the company a buy rating in a report on Friday, February 9th. William Blair reaffirmed an outperform rating on shares of Encompass Health in a research note on Wednesday, February 7th. Barclays boosted their target price on Encompass Health from $95.00 to $101.00 and gave the company an overweight rating in a research note on Thursday, March 28th. Finally, Stephens reaffirmed an overweight rating and set a $85.00 price target on shares of Encompass Health in a research report on Tuesday, January 16th. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of Buy and an average target price of $84.67.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.